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Abstract: Background: Three Cochrane reviews show that music therapy has a positive effect
on schizophrenia concerning general functioning and positive/negative symptoms. This study
aims to replicate these results in the Danish health system, a requirement for recommendation
in guidelines from the Danish National Board of Health. Methods: The study is a randomized,
controlled multi-site study, with a blinded design, aiming to include 90 participants who are
18–65 years in age, diagnosed according to ICD-10 with a schizophrenia diagnosis. The participants
are randomized to one of two different music therapy activities for 25 weekly sessions. The study
interventions are added to standard care. Outcome measures are rated at baseline, after 15 sessions
and post therapy. A qualitative interview is performed as a one month follow up at the end of
study. The primary intended outcome is a reduction in negative symptoms. The secondary intended
outcome is progression in quality of life, alliance and psychosocial functioning. Results: As this study
is still running, the results are not yet available. Conclusion: The study will investigate the direct
effects of music therapy on negative symptoms as part of schizophrenia in a blinded, randomized
trial. If proven effective, music therapy can be added to the small treatment armamentarium of
effective therapies for negative symptoms in patients with schizophrenia.
Keywords: schizophrenia; negative symptoms; isolation; music therapy treatment
1. Introduction
1.1. Background
The background for this study is based on three factors: (1) The treatment possibilities for
the population under investigation are poor; (2) National Boards of Health in different countries
recommend music therapy differently as a treatment possibility; (3) Music therapy has shown positive
results in previous studies, where music therapy was added to standard care and compared to standard
care alone. All three factors indicate that more evidence-based research is needed, with an active
comparator as the second arm within the field.
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The World Federation of Music Therapy (WFMT) produced the first common definition in 1996,
and the most recent version from 2011 reads as follows: “Music therapy is the professional use of
music and its elements as an intervention in medical, educational, and everyday environments with
individuals, groups, families or communities who seek to optimize their quality of life and improve
their physical, social, communicative, emotional, intellectual and spiritual health and wellbeing.
Research, practice, education and clinical training in music therapy is based on professional standards
according to cultural, social and political contexts” [1].
1.1.1. Treatment Possibilities
Negative symptoms of schizophrenia have gone from being described as the primary feature of
schizophrenia to being a secondary phenomenon [2]. Negative symptoms have been correlated with a
lower quality of life, lower overall social and global functioning, as well as being associated with a
decline in cognitive function [2]. Despite the correlation between negative symptoms and key areas
of living, few studies have investigated possible treatments for the symptom cluster, and even fewer
have showed an effect in the treatment thereof [3].
1.1.2. Recommendation of Music Therapy for the Population
Previous studies have shown that music therapy can be an effective psychosocial treatment
approach [4–7]. Based on these studies, art therapy, including music therapy, has since 2014 been
recommended as a treatment method for patients diagnosed with schizophrenia in the National
Institute for Health and Care Excellence (NICE) guidelines (UK) to promote recovery. It is stated that
“...art therapies should be recommended to all people with psychosis or schizophrenia, particularly for
the alleviation of negative symptoms.” [8].
The NICE guidelines justify their recommendation by stating that people with schizophrenia
should be enabled to experience themselves differently, to be offered new ways of relating and
expressing themselves and organizing their experiences into a satisfying aesthetic form ([8] p. 593).
The Royal Australian and New Zealand College of Psychiatry claimed in 2016 that the evidence
from randomized, controlled trials in music therapy is inconclusive. Therefore, more studies
investigating the effects of music therapy in this patient group are warranted before music therapy can
be recommended as a standard treatment [9].
In Norway, the national treatment guidelines from (Helsedirektoratet) state that music therapy
promotes wellbeing and that the treatment should start as early as possible in order to reduce negative
symptoms (our translation) [10].
In Denmark, music therapy is not recommended in the treatment guidelines for schizophrenia
in The Danish National Board of Health. It is recommended to “...develop and prove more effective
psychosocial evidence-based treatment methods for this population” (our translation) ([11], p. 51).
This study is an attempt to contribute to the development of evidence-based treatment methods.
1.1.3. Previous Positive Results
Three Cochrane reviews [4,6,7] have shown the positive effect of music therapy in patients
diagnosed with schizophrenia, with an improvement of several general symptoms (among others,
attention and motivation) and a reduction of negative symptoms. The main intervention methods
of the studies have been (1) musical improvisation (where the music therapist plays a frame around
the expression of the client and thus helps provide a musical structure where the client can feel
like being a real part of interplay) and (2) song-writing (where the music therapist helps the client
to structure texts made by the client and create a melody and musical accompaniment so they can
sing the song, based on the text by the client, together. The studies were based on humanistic,
resource-oriented and psychodynamic approaches. In all studies included, music therapy was added
to standard care and compared to standard care alone. These reviews do not examine which elements
in music therapy contribute to the overall effects observed. Qualitative research in the form of
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case studies has elucidated which elements in music therapy are assumed to be effective in the
treatment. Musical elements, as well as elements in the therapeutic relationship seem to be crucial.
Basic communication elements such as turn-taking in giving and taking a tone, a rhythm or a small
melody are assumed to be effective in musical communication [12–14]. Additionally, joint musical
expression at a very slow tempo, with as many repetitions as needed, are assumed to be effective in
musical interplay [15,16]. These communication forms would not be as effective or meaningful in verbal
communication. Furthermore, patients report it is meaningful to play or vocalize simultaneously
with the therapist when the therapist follows the expression of the patient either in the form of
imitation, matching or affective attunement [17]. These mechanisms are not so accessible in verbally
mediated treatment.
Research on music and the brain has shown that the perception of music indicates that music
and specifically music listening can positively affect brain chemistry. Among other effects, music
listening can strongly affect and change activities in brain areas connected to emotional regulation
and social response, such as the limbic and paralimbic structures [18]. This is in line with research
showing that listening to preferred or selected music in the form of playlists can regulate emotions
and moods in different ways [19,20]. Finally, qualitative research based on the analysis method of
grounded theory in music therapy in patients diagnosed with schizophrenia, or those who present
schizotypical disorders, has shown improvements in music listening, where the focus of the individual
evokes inner imagery which can be shared verbally with a group of clients and the therapist [21].
Smaller studies, where mutual music improvisation among the therapist and client in a 1:1 setting was
the applied intervention, also point at the importance of how the music therapist is consciously present
in the therapeutic relationship when working with this population [22–25]. A general focus in these
studies is on the therapist’s listening attitude and the therapist’s consciousness of being present in a
disciplined state of being. Here, the therapist identifies with the patient’s state of being by consciously
imitating and following the state of being of the patient, as expressed through musical interplay in the
beginning. Gradually, with the right timing, the therapist can start to differ in musical expressions
through small variations in musical expressions, gradually moving to a more inter-subjective state of
being together, where both are engaged in the interplay as two subjects playing together [15,24,26,27].
Based on these factors, the aim of this study is to investigate whether music therapy can reduce
negative symptoms in patients diagnosed with schizophrenia by using a randomized, controlled and
blinded study design with an active comparator for the interventions. Furthermore, the study aims to
examine if individual music therapy can increase the quality of life and establish progression in the
alliance in the therapeutic relationship. Lastly, the study aims to investigate if the intervention can
support and improve psychosocial functioning.
1.2. Hypothesis
We hypothesize that participants who are randomized to group I (the experimental group),
when performed by educated and experienced music therapists offering multiple music therapy
techniques adapted to the needs of the participant, will have a larger reduction in negative symptoms
as measured by the clinical rating scale than participants who attend group II (the control group),
where music is performed by non-music therapists, offering solely music listening. Furthermore, we
hypothesize that participants randomized to group I will experience a larger increase in quality of life
and in the progress of alliance building and psychosocial functioning as compared to group II.
2. Materials and Methods
2.1. A Randomized, Controlled and Blinded Study
The examination is a randomized, controlled, multi-site study, applying a blinded design
including 25 sessions of manualized music therapy for the intervention group (group I) and 25 sessions
of manualized music listening to selected playlists for the second arm with an active comparator
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(group II). The number of sessions is based on research concerning the dose response effect for
music therapy for people with serious mental disturbances [28]. The arms of interventions are
called intervention I and intervention II in the present study. Participants are rated at baseline, after
15 sessions and after 25 sessions post-therapy. At follow up (four weeks after post therapy at the end
of study), a short, semi-structured interview will be performed with all participants. (See Table 1).
Before baseline, all participants are informed (1) that they will be offered 25 sessions of music therapy,
(2) that two different activities will be tested and compared (3) and that those performing the sessions
are all referred to as therapists and are familiar with being together with people diagnosed with
schizophrenia. (4) The participants will also be informed that recording of the musical activities
might occur. All sessions will take place in the same equipped music therapy rooms. Intervention
I is carried out by trained and experienced music therapists who are familiar with the population
under examination, being carefully trained in and following a manual developed for this intervention
in the study. Professional music therapists in Denmark all have a five-year full-time university
BA/MA training, including several internship periods [29]. This training is based on a psychodynamic,
humanistic and neuropsychological theoretical platform and is structured in three parallel running
study tracks with equal weight through all five years. These tracks include an academic theoretical
study track, a music-based improvisational methodological study track and a psychotherapeutic,
self-experiential and clinical study track [29]. Due to the manual for Group I several music therapy
methods and techniques can be applied including active methods (where the therapist and participant
play or sing together, improvise, write songs or move to music), as well as receptive methods (where the
therapist and participant listen to music together, either in the form of playlists selected by the music
therapist, or in the form of participant-chosen or therapist-chosen music). The focus of the manual is
about perspectives on the therapist’s way of being present and positions in the therapeutic relationship.
Intervention II is carried out by non-music therapists who are familiar with the population under
examination, being carefully trained in and following a manual developed for this intervention in
the study. Intervention II includes solely listening to specific playlists developed by music therapists.
(This intervention is similar to one of the possible intervention methods in intervention I and thus both
intervention forms can be called music therapy activities). All therapists performing intervention II
are trained how to apply the playlists by a music therapist. Therapists performing intervention I have,
as a premise, the possibility of applying multiple music therapy techniques, including the selected
playlists. Their choice of techniques is currently adapted to the needs of the participants. Both manuals
are developed according to unique, essential, possible and not-possible/proscribed principles for
interventions and for the attitudes of the therapist in work with this population [30,31].
All participants included in the study and clinical personal accessing the participants will be
blinded. Therapists, investigators and other researchers in the research steering group, including those
who make the qualitative analysis as part of the data collection, will not be blinded. The participants
will be rated with the scales and measures listed below in Section 2.4.
For analyzing musical communicative capacities, only those attending intervention I will additionally
be subject to audio recordings of musical improvisations in sessions 1, 15 and 25 (if improvisation
is performed in those sessions), as musical improvisation is not a part of intervention II. Finally,
the therapy session reports about the participants’ experiences of music listening, experiences of music
performance and level of initiative in verbalization will support the results as a whole.
The study involves two regions in Denmark: The North Jutland Region and the Capital Region.
Within these regions, nine municipalities are involved. A cooperation agreement is signed for each
region and for each of the municipalities.
Medicines 2019, 6, 46 5 of 15
2.2. Recruitment Processes
In the recruitment process, administrative and/or research heads of psychiatric centers will be
contacted, and information meetings for daily contact persons for potential participants will be carried
out at all centers that show interest in cooperation. Posters and leaflets will be spread throughout the
centers and further information meetings will be offered if needed. These meetings often take place
in two steps. The first step includes meeting with the contact person(s) alone and the second step is
meeting with the contact person(s) and those diagnosed with schizophrenia, who have shown interest
and who are supposed to be potential participants. After a trial period of five months, we learned that
in each center, a contact person should be appointed to remind staff members to refer and to collect
referrals and forward these with the needed information to the research coordinator. The coordinator
receives the name, telephone number and e-mail address of the participant through secure mail. Both
the potential participant and the contact person are permanently in contact with the coordinator (the
same person for all participants in respectively the Region of North Jutland and the Region of the
Capital) about potential questions around participation. The coordinator arranges for the inclusion
screening procedure. At this first screening procedure, the project nurse asks the participant to sign
an informed consent form in order to provide allowance to receive information of diagnosis, medical
information and the hospitalization history of the single participant. If this is not possible, the client
cannot be included in the study. The informed consent for taking part in the project as a whole is
also signed at the first screening procedure after further information of the conditions involved in
the study. After randomization, the coordinator will connect the participant and a relevant therapist,
scheduling sessions at the equipped music therapy clinic room, located as close as possible to where
the participant is living. If the participant is unable to take public transport, taxi tickets can be offered.
The coordinator takes care that a time schedule for 25 sessions is made by the therapist and accepted by
the participant. The therapist receives information of the name, telephone number and email address
for both the participant and the contact person. The coordinator registers these sessions using Google
Calendar. He is the person who will coordinate all screening procedures and interviews throughout the
participation period of the single participant, due to the rules of the research design. All information
about the single participant will be saved on a secure electronic drive.
The coordinator ensures that all relevant information is available and coordinates the inclusion
screening procedure between the participants and the project nurse (screener). If the screening
procedure results in inclusion, the participant is randomized by the Hospital Pharmacy, Region of
Northern Jutland, which is not otherwise involved in the present study. A random variable block size
randomization will be utilized in the study. The first session will take place no later than 14 days after
the screening procedure to ensure the validity of the positive and negative syndrome scale (PANSS)
evaluation conducted at the first screening. The study coordinator is responsible for assigning a
relevant therapist, scheduling sessions and booking session rooms.
2.3. Inclusion and Exclusion Criteria
2.3.1. Inclusion Criteria
The inclusion criteria are as follows:
(1) Age 18–65 years;
(2) Diagnosis of schizophrenia by ICD-10 (F20);
(3) PANSS negative subscale, minimum ≥4 on two of the following items, blurred affect (N1),
emotional withdrawal (N2), poor contact (N3), passive apathetic social withdrawal (N4) and lack
of spontaneity and flow in dialogues (N6).
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2.3.2. Exclusion Criteria
The exclusion criteria are as follows:
(1) Diagnosis of schizophrenia less than two years ago;
(2) Patients hospitalized less than three months ago due to their psychiatric illness;
(3) PANSS positive subscale (P1–P7) > 28;
(4) Patients who have had changes in psychotropic treatment during the last month;
(5) Significant alcohol/drug abuse that may interfere with study participation, as judged by
the investigator;
(6) Presence of secondary negative symptoms, defined as:
(a) Calgary Depression Scale for Schizophrenia (CDSS) score >7 or;
(b) Neurological side-effects UKU score >1 in the following items: Dystonia (2.2), rigidity
(2.3), hypokinesia/akinesia (2.5), tremor (2.6) and motor akathisia or;
(c) Sedative side-effect UKU item (1.3) or a sleepiness score >1;
(d) Patients who have attended individual music therapy within the last 2 months.
2.3.3. Treatment Schedule and Withdrawal Criteria
The treatment schedule is constructed to offer weekly sessions of 50 min of music therapy
activities each 7 day +/− 1 day, resulting in a minimum of five days and a maximum of nine days
between sessions. A session plan of 25 sessions is scheduled before the start of intervention and is
accepted by the participant. If the participant fails to meet up to any of the scheduled sessions, with or
without notice, the session will not be replaced. If the therapist cancels any of the scheduled sessions,
replacements will be offered. The 25 scheduled sessions exclude holiday weeks. Participants will
be withdrawn from the study as a whole if more than 30 days pass between two sessions or if the
participant fails to turn up for more than five sessions. The participant will be reminded and warned
by telephone if they fail to appear at three and four of the scheduled sessions, with a reminder of
exclusion from further participation if a total of more than five lacking appearances occur. They will
also be reminded if more than three weeks between scheduled sessions pass, often as part of a holiday,
resulting in it being mandatory to attend the week after the holiday. Each therapist in the study is
not allowed to plan for more than three combined weeks of holiday during each treatment schedule.
Each time the participant fails to turn up without notice, the therapist will contact the participant to
ensure the participant is safe and has planned not to attend this session. The participant will also be
withdrawn from the study if they withdraw their informed consent. If hospitalization occurs during
the study, the participant can continue in the study as long as the duration is short term (<5 days) and
no change in medication has occurred.
Withdrawing from the study will in no way affect the individual participants’ treatment as usual.
2.4. Outcomes
The outcome measures include primary and secondary outcomes. The primary outcome measure
is a change in the PANSS negative subscale from baseline to the end of the study. The secondary
outcomes are a change in Brief Negative Symptom Scale (BNSS), measurement of quality of life,
the capacity of building an alliance, global functioning and for the experimental group, musical
communication ability from baseline to the end of the study (see Figure 1).
Medicines 2019, 6, 46 7 of 15
Medicines 2018, 5, x FOR PEER REVIEW    7  of  16 
 
 
Figure 1. Flow diagram of the experiment design. As the recruitment process is currently running, 
only the inclusion data can be presented. 
2.4.1. Negative Symptom Measurements 
As we  are  investigating  the  effect of music  therapy on negative  symptoms  in patients with 
schizophrenia,  we  wished  to  evaluate  this  symptom  domain  as  carefully  as  possible.  When 
measuring  negative  symptoms,  symptoms  can  be divided  into  primary  and  secondary  negative 
symptoms. The primary symptoms are the core negative symptoms which are not a consequence of, 
for example, the side‐effects of drugs, depression or a lack of social activity. As a result, we wished 
to have a measure of negative symptoms (PANSS and BNSS), as well as measure symptom domains 
which  can  present  themselves  as  negative  symptoms. As  a  result, we  have  chosen  to measure 
depressive  symptoms  (CDSS)  and medication  side‐effects  (UKU)  in  addition  to  the  scales  that 
measure negative symptoms specifically. 
The  Positive  and  Negative  Syndrome  Scale  (PANSS)  consists  of  seven  items  for  positive 
symptoms,  seven  items  for  negative  symptoms  and  16  items  for  the  evaluation  of  general 
psychopathology.  The  PANSS  is  validated  and  verified  and  is  standard  in  effect  studies  of 
antipsychotics  [32,33].  The  Structured  Clinical  Interview‐PANSS  (SCI‐PANSS)  is  a  structured 
interview designed to help the interviewer in getting the information needed to perform the rating. 
The SCI‐PANSS will be used in the study [33–35]. Interrater reliability has been shown to be good on 
the  full PANSS  scale  score, with  intraclass  coefficients of  0.98–0.99, with an acceptable  interclass 
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only the inclusion data can be presented.
2.4.1. Negative Symptom Measurements
As we are investigating the effect of music therapy on negative symptoms in patients with
schizophrenia, we wished to evaluate this symptom domain as carefully as possible. When measuring
negative symptoms, symptoms can be divided into primary and secondary negative symptoms.
The primary symptoms are the core negative symptoms which are not a consequence of, for example,
the side-effects of drugs, depression or a lack of social activity. As a result, we wished to have a
measure of negative symptoms (PANSS and BNSS), as well as measure symptom domains which
can present themselves as negative symptoms. As a result, we have chosen to measure depressive
symptoms (CDSS) and medication side-effects (UKU) in addition to the scales that measure negative
symptoms specifically.
The Positive and Negative Syndrome Scale (PANSS) consists of seven items for positive symptoms,
seven items for negative symptoms and 16 items for the evaluation of general psychopathology.
The PANSS is validated and verified and is standard in effect studies of antipsychotics [32,33].
The Structured Clinical Interview-PANSS (SCI-PANSS) is a structured interview designed to help the
interviewer in getting the information needed to perform the rating. The SCI-PANSS will be used
in the study [33–35]. Interrater reliability has been shown to be good on the full PANSS scale score,
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with intraclass coefficients of 0.98–0.99, with an acceptable interclass coefficient of 0.83–0.90 when
using the SCI-PANSS interview [36]. Part of the PANSS rating is video recorded and kept in the data
collection, as to furthermore enable analyses of interrater reliability.
The Brief Negative Symptom Scale (BNSS) consists of 6 subscales and 13 items on anhedonia,
distress, asociality, avolution, blunted affect and alogia. The advantage of the scale is a separation of
appetitive and consummatory anhedonia, asociality and internal experience. It has a threefold aim of
examination (knowledge of behavior, of the social context and of the report of the experience of the
participant concerning everyday life) [37].
2.4.2. Quality of Life and Capability of Attachment Measurements
WHOQOL-Bref (Quality of Life) is a self-reported questionnaire containing 26 items. Each item is
rated on a Likert-type scale ranging from zero to five, where zero is very bad and five is very good [38].
The Helping Alliance Questionnaire (Patient Version) (Haq-II) is a self-reported questionnaire
containing 19 items rated on a Likert-type scale with a score from zero to six, spanning from do not
agree at all to total agreement [39]. The measurement tool is important to investigate if a potential
reduction of negative symptoms may increase the ability of building alliances. A former research
project showed positive results in the increase of alliance building in music therapy treatment in a
study population including patients diagnosed with schizophrenia [40].
2.4.3. Measuring Secondary Negative Symptoms
The Calgary Depression Scale for Schizophrenia (CDSS) is used as a scale of depression for
schizophrenia. Depression symptoms can be difficult to differentiate from the negative symptoms seen
in schizophrenia. The CDSS consists of nine items. The CDSS is reliable and valid for the evaluation
of depression in schizophrenia, and in differentiating depression from negative symptoms when
combined with PANSS [41]. Each item can be given a score between 0 and 3, which gives a total score
between 0 and 27. Light depression is defined as a total score ≥3 but <7, moderate depression is
defined as a total score ≥7 but <11 and severe depression is defined as a total score ≥11.
UKU is an acronym for the Danish name “Udvalg for Kliniske Undersøgelser” (Task Force for
Clinical Investigations). The UKU side-effects scale is used for a general assessment of side-effects
induced by treatment with antipsychotics. The UKU scale is divided into four main areas: Mental,
neurological, autonomic and other side-effects, containing a total of 48 items rated by the clinician [42].
2.4.4. Measuring State of Functioning
The Global Assessment of Functioning (GAF) scale is a clinical evaluation of the participant’s
overall function levels. Generally, it includes psychological, social, interpersonal and occupational
functioning in regard to mental-health illness. The scale ranges from 0–100, with a higher number
indicating superior functioning [43].
2.4.5. Measurement of Musical Communication Ability
The Musical Interaction Rating Scale (MIR(S)) is applied solely for participants in group I if
musical improvisation takes place in sessions 1, 15 and 25. It is a non-standardized tool specifically
created for music therapy to analyze and rate musical interactions (the musical contact) between the
participant and the therapist. Ten items are rated, ranging from no contact to fluent contact between
the therapist and participant [44–46].
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Table 1. A SPIRIT diagram on screening procedures.
Screening Baseline After Fifth before SixthOffered Session
After Fifteenth before Sixteenth
Offered Session
Less Than Eight Days after the Last
Session
Termination 1
Follow up
4–5 Weeks after
Termination
No of visit 1 2 3 4 5 6
Performed by 2 MT/T RP PN MT RP PN MT RP RP
Information and consent x
Demographical data 3 x x
Status of medicine x x 4 x x
History of abuse x x 4 x x
History of music therapy 5 x x 4
Inclusion and Randomization X
PANSS x x 6 x x
Brief Negative Symptom Scale (BNSS) x x 4 x x
WHOQOL x x 4 x x
Calgary Depression Scale for Schizophrenia (CDSS) x x 4 x x
Udvalg for Kliniske Undersøgelser (UKU), otherwise
Task Force for Clinical Investigations x x
4 x x
Global Assessment of Functioning (GAF) x x 4
Helping Alliance Questionnaire (HAQ-II) x x x
MIRS
Only experimental group I x x x
Start of weekly interventions, groups I and II x
Start McGlashan rating after each intervention for
experimental group I x
Termination of weekly interventions for groups I and II x
Interview x
1 Is not performed if screening procedure after fifteenth session but before sixteenth offered session is performed ≤14 days earlier. 2 PN = rroject nurses; MT = music therapists group I,
therapist group II; RP = research participant. 3 Sex, age, ethnicity, level of education, social and work situation. 4 Is not performed if performed by screening ≤28 days earlier. 5 Music
therapy and other formalized music related offers other than trial treatment are registered. 6 Is not performed if positive and negative syndrome scale (PANSS) in screening is performed
≤14 days earlier.
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2.4.6. Other Measurements
For each session, a detailed therapy session report is filled in. Different versions of the reports
are available depending on which group the participant is randomized to. The report documents
attendance, choice of techniques by the therapist, choice of music by the therapist or the participant,
and finally the musical and verbal initiative of the participant.
At the four weeks follow-up, a semi-structured interview will take place, performed by the same
researcher for all participants. A four-week timespan was chosen as the participants most commonly
are chronically ill, and cognitive deficits could result in recall bias.
The interview is structured in two parts. The first part consists of short questions about self-experienced
progressions concerning the participant’s work situation, family and social relationships and activities
and personal issues (self-reliance concerning hygiene and cleaning). The second part consists of open
questions about the participant’s experiences of joining the music therapy activity sessions. To create a
safe setting around this interview, it is important that there is sufficient time and that it is performed
where the participant wants the session to take place (e.g., at the participant’s private home, at a bench
close to home, in the same room as the music therapy activities have taken place or at the place of the
screening procedures).
2.5. Data Collection and Management
Case Report Form and REDCap
All data from the screening procedures will be collected in a case report form for each participant,
excluding the semi-structured qualitative interview data and session schedule data. All data collected
will further be entered into a REDCap electronic database, utilizing double entry to minimize the
risk of errors. All information from the case report forms will be stored by the Aalborg University
Hospital Psychiatry Department. When screening procedures take place on sites away from the
hospital, the screening data of each case will be kept in a client project report, which is held securely
until the project leader transports the data files to the hospital where they are entered into REDCap.
Data from semi-structured interviews and session schedules will be stored by The Music Therapy
Clinic, an integrated institution between Aalborg University and the Aalborg University Hospital
Psychiatry Department. Therapy session reports are sent by each of the therapists immediately
after each session by secure mail to the coordinator, who saves the files at a secure electronic drive.
Qualitative interviews are kept by the interviewer in a locked closet until the study is finished and the
data have to be analyzed. These data are not entered into REDCap.
2.6. Ethical Approval
Different Approvals
This study protocol is approved by The Regional Committee on Biomedical Research Ethics,
Region of Northern Jutland, Denmark (ID N-20150054) and the Data Protection Agency of Denmark
(2015-144). The study is performed in accordance with the Declaration of Helsinki. Written informed
consent forms will be obtained before participant inclusion in the study. A detailed signed cooperation
agreement between the university and the hospital is developed for this study and a signed agreement
from the heads of psychiatric centers from each community will be required before any recruitment
can be initiated. The study is registered in TrialRegistration.gov (ID number NCT02942459) registered
retrospectively since October 2016.
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2.7. Sample Size
Estimation of Sample Size
Utilizing previous data, we estimated an effect size of 0.6 (medium effect according to Cohen’s d).
With a selected level of significance of 0.05 and a power of 0.8, a power calculation performed in R with
a conservative approach (applying a two-sided t-test with two samples), resulted in each group having
to count a minimum of 44.5 persons. The data utilized in the power calculation did not use an active
comparator, which might result in a lower effect size in the current study. We furthermore estimate a
drop-out of 10–20% of participants, resulting in an estimated required sample size of 60 persons in
each group.
3. Results
3.1. Statistical Analysis
3.1.1. Form of Statistical Analysis
As the study is still running, no final results are available. The results will be generated
through statistical analysis where the endpoints from PANSS, BNSS and WHOQOL-BREF will be
analyzed using mixed model effect analysis. Predictors for the response to the treatment will be
performed by multiple logistic regression, using the severity of psychiatric disorders, timespan from
diagnosis identified, psychotropic medication, PANSS score results and regional contra communal
treatment as usual, as explanatory variables with a regression model being performed for each of
the two randomized groups. The analysis will focus on identifying predictors of improvement
of negative symptoms and change of quality of life, alliance and global functioning, as well as
predictors for improvement connected to treatment (music therapy activities I or II). Both per protocol
and intention-to-treat analyses will be performed. Intention to treat is defined as utilizing data
from all participants, even if the single participant has not attended all 25 sessions. At the time of
discontinuation from the study, a final assessment will be conducted, if possible. Participants will not
be followed up on after this time point.
All tests will be applied double sided and the significance limit is defined as p < 0.05.
3.1.2. Analysis of Compliance
A sensitivity analysis will compare compliance versus non-compliance. Compliance will be
calculated based on the number of sessions received divided with number of sessions offered and
multiplied by one hundred.
3.1.3. Qualitative Analysis
During the semi-structured follow-up interviews, the interviewer will write down each word
expressed by the participant. Most participants are rather short of words and need time to formulate
their experiences. Each word in the written material is read out loud for the participant at the
end of the interview to ensure the participant agrees to what is reported and that they accept the
text. This procedure replaces member checking with this population, as audio recording mostly
has a disturbing effect, and as they might have difficulties in remembering what they expressed,
having a written text for several weeks later is very helpful. The texts will be analyzed through
phenomenological analysis and will add to the results in the form of short theme-based narratives on
developments in work situation, social and relational issues and patient reported overall experiences of
participation in the study. Additionally, music improvisation analysis will add to the results concerning
progression in levels of contact in the musical interplay of the therapeutic relationship.
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4. Discussion
4.1. Blinded Design as an Innovation
This study is the first study in music therapy in patients diagnosed with schizophrenia using
a randomized, controlled and blinded design. There are numerous studies and Cochrane reviews
showing the positive results of music therapy on global functioning, including negative symptoms in
patients diagnosed with schizophrenia where music therapy was added to standard care, comparing
this to standard care alone [4,6,7].
This study will investigate if negative symptoms can be reduced when participants are offered
music therapy performed by a professional music therapist, as compared to an active comparator
where music listening to selected playlists is performed by a non-music therapist. The design adjusts
for the Hawthorne effect, which may positively bias results of an intervention when only comparing
this to standard care. This study will only capture the immediate effect on negative symptoms (if any)
of the intervention. A four week follow-up includes solely a qualitative interview (see Section 2.4.6),
where the subjective experiences of the participants can be unfolded. The timespan for this follow-up
is rather short and could be claimed as a limitation of the study. As mentioned above, the four weeks
timespan was chosen as the participants most commonly are chronically ill and cognitive deficits could
result in recall bias.
4.1.1. Challenging in Blinding
We are aware that the blinding of participants, as performed in this study, cannot be compared to
a placebo blinding, as the intervention is a face to face procedure, and the therapists performing the
interventions are not blinded.
4.1.2. Challenges of the Design
We are also aware that applying a design as close to a biomedical design as possible, in an
examination of a population with a complex disease and with low motivation for participation,
is ambitious. We are prepared for challenges. We plan to cooperate with relevant staff members and
relatives concerning motivation, attendance and other experienced challenges by the participants.
5. Conclusions
Reduction in Sample Size Due to Challenges
The trial status is currently ongoing. Recruitment started in March 2016 and will continue until
the end of May 2019, with the expected last participant visit in December 2019. Due to low rates of
recruitment, a total of 47 participants have been included by November 2018, from the 177 referred to
the study (see Figure 1). We currently aim to include a total of 60 participants. Concerning blinding,
we have currently been informed that three participants receiving intervention II have expressed that
they know they are not receiving music therapy due to previous experiences with music therapy.
So they are not blinded. This will be transparent in the analysis of the data. In spite of challenges
concerning motivation and attendance, many participants have so far been able to attend all sessions
offered. The results of the current trial will be widely disseminated at national and international
scientific conferences and in further scientific articles.
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